A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant | MicrobiomeTrials
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-09-09Est. Completion: 2030-02-14
Enrollment target: 46 participants
Locations
City of Hope Medical Center, Duarte, California, United States
Northside Hospital, Atlanta, Georgia, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in